Response To: ‘High Prevalence of Hepatitis C Infection Among Multidrug-Resistant Tuberculosis Patients’ by Seung KJ Et Al

Journal of Hepatology - Netherlands
doi 10.1016/j.jhep.2020.01.020
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Elsevier BV

Related search

Prevalence of Latent Tuberculosis Among Household Contacts of Patients With Multidrug‐resistant Tuberculosis in Vietnam

Respirology
PulmonaryRespiratory Medicine
2019English

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection With Multidrug-Resistant Enterobacteriaceae

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2016English

Prevalence of Resistance to Second-Line Tuberculosis Drug Among Multidrug-Resistant Tuberculosis Patients in Viet Nam, 2011

Western Pacific surveillance and response journal : WPSAR
Medicine
2016English

Prevalence of Hepatitis C Virus Infection and Response to Hepatitis B Vaccination Among Egyptian School Children

International Journal of Medical Science and Public Health
2017English

Hypokalemia Among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Patients

Korean Journal of Internal Medicine
Internal Medicine
2019English

Prevalence of Latent Tuberculosis Infection Among Patients With Lung Cancer

Respirology
PulmonaryRespiratory Medicine
2019English

Reply to Anthony Et Al., “Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment”

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy